CTSH and Alzheimer disease: Furthermore, our colocalization analysis found the evidence of one functional variant in CTSH affecting both Cathepsin H levels and AD risk in all three tissues (posterior probability PP.H4 = 0.995 in brain; PP.H4 = 0.960 in CSF; PP.H4 = 0.948 in plasma).